Description
Scripps MD Anderson Cancer Center 34th Annual Cutaneous Malignancy Update Melanoma 2024
- Include: 23 videos + 1 pdf, size: 4.06 GB
- Target Audience: dermatologist, pathologist, dermatopathologist, primary care physician
- Sample video: contact me for sample video
Information:
Conference Overview
As the incidence of melanoma continues to rise rapidly in the United States and around the world, the need to educate clinicians from various specialties on the disease also increases. During this course nationally recognized experts will present information on prevention, risk assessment, early detection, genetic factors, and current and future treatment choices for melanoma patients.
Issues concerning surgical management, adjuvant therapy, advanced disease therapy, and personalizing the course of treatment for individual patients will also be discussed. This course is designed to provide information that will help clinicians in their decision making regarding these difficult patient problems. The course will be taught by a wide range of experts as this most serious of skin cancers will require multidisciplinary efforts to conquer.
Educational Objectives
After attending this live activity, participants should be able to:
• Describe the epidemiology and risk factors associated with the increasing incidence of cutaneous melanoma.
• Evaluate and diagnose a variety of malignancies related to melanoma skin cancer.
• Identify possible genetic mutations and etiologic factors in the melanoma patient and diagnose patients based on dermatologic manifestations.
• Integrate new therapies and treatments for advanced melanoma including surgical techniques.
• Discuss the effectiveness of neoadjuvant therapy and immunotherapy in treating melanoma.
• Develop strategies for managing patients with multiple melanomas and awareness of task of 2nd primary.
Target Audience
• Dermatologists
• Pathologists
• Dermatopathologists
• Primary Care Physicians
• Dermatology Nurses/Nurse Practitioners/Physician Assistants
Topics:
- brochure_mel24_compressed.pdf
- Jan 27 Case Presentations 1.mp4
- Jan 27 Case Presentations 2.mp4
- Jan 27 Cutting Through Complexity Surgical Insights in Melanoma of the Head and Neck.mp4
- Jan 27 Dysplastic Nevi Navigating the Risk Landscape.mp4
- Jan 27 Enhanced Melanoma Reporting and The Ohio Model.mp4
- Jan 27 Innovations in Diagnostic Techniques for Melanoma.mp4
- Jan 27 Insights into Sentinel Node Evaluation 2024 Update.mp4
- Jan 27 Melanoma, the Primary Lesion Biopsy, Excision and Mohs Surgery in Selected Case.mp4
- Jan 27 Melanonychia Diagnosis, Evaluation, and Treatment.mp4
- Jan 27 Ministering to the Melanoma Patient.mp4
- Jan 27 Neoadjuvant Breakthroughs in Advanced Resectable Melanoma.mp4
- Jan 27 Ocular and Periocular Melanoma.mp4
- Jan 27 Pathology of Melanoma Current Status and Prognostic Indicators.mp4
- Jan 27 Radiation Therapy for Melanoma Including Lentigo Maligna.mp4
- Jan 27 Sun Exposure and Melanoma Connecting the Dots.mp4
- Jan 28 A Fresh Look at Oncolytic Immunotherapy.mp4
- Jan 28 Beyond the Primary Comprehensive Evaluation of the Melanoma Patient for Oddities.mp4
- Jan 28 Case Presentations.mp4
- Jan 28 Cutaneous Toxicities of Immune Therapy.mp4
- Jan 28 Melanoma in the Molecular Age Part 1 New Tools for Diagnosis, Prognosis.mp4
- Jan 28 Melanoma in the Molecular Age Part 2 New Tools for Diagnosis, Prognosis.mp4
- Jan 28 Melanoma Medical Legal Complications.mp4
- Jan 28 Metastatic Evaluation of the Melanoma Patient.mp4
